319 related articles for article (PubMed ID: 16536894)
1. Methods to assess drug permeability across the blood-brain barrier.
Nicolazzo JA; Charman SA; Charman WN
J Pharm Pharmacol; 2006 Mar; 58(3):281-93. PubMed ID: 16536894
[TBL] [Abstract][Full Text] [Related]
2. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
3. The highly permeable blood-brain barrier: an evaluation of current opinions about brain uptake capacity.
Fagerholm U
Drug Discov Today; 2007 Dec; 12(23-24):1076-82. PubMed ID: 18061888
[TBL] [Abstract][Full Text] [Related]
4. Current in vitro and in silico models of blood-brain barrier penetration: a practical view.
Vastag M; Keseru GM
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):115-24. PubMed ID: 19152220
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
6. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
7. Blood-brain barrier imaging and therapeutic potentials.
Rebeles F; Fink J; Anzai Y; Maravilla KR
Top Magn Reson Imaging; 2006 Apr; 17(2):107-16. PubMed ID: 17198226
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.
Wang Q; Rager JD; Weinstein K; Kardos PS; Dobson GL; Li J; Hidalgo IJ
Int J Pharm; 2005 Jan; 288(2):349-59. PubMed ID: 15620875
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of in vitro brain penetration: optimized PAMPA and MDCKII-MDR1 assay comparison.
Carrara S; Reali V; Misiano P; Dondio G; Bigogno C
Int J Pharm; 2007 Dec; 345(1-2):125-33. PubMed ID: 17624703
[TBL] [Abstract][Full Text] [Related]
10. In vivo, in vitro and in silico methods for small molecule transfer across the BBB.
Mensch J; Oyarzabal J; Mackie C; Augustijns P
J Pharm Sci; 2009 Dec; 98(12):4429-68. PubMed ID: 19408294
[TBL] [Abstract][Full Text] [Related]
11. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
12. An in vitro blood-brain barrier model for high throughput (HTS) toxicological screening.
Culot M; Lundquist S; Vanuxeem D; Nion S; Landry C; Delplace Y; Dehouck MP; Berezowski V; Fenart L; Cecchelli R
Toxicol In Vitro; 2008 Apr; 22(3):799-811. PubMed ID: 18280105
[TBL] [Abstract][Full Text] [Related]
13. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
Pardridge WM
Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
[TBL] [Abstract][Full Text] [Related]
14. Challenges for blood-brain barrier (BBB) screening.
Jeffrey P; Summerfield SG
Xenobiotica; 2007; 37(10-11):1135-51. PubMed ID: 17968740
[TBL] [Abstract][Full Text] [Related]
15. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
[TBL] [Abstract][Full Text] [Related]
16. Progress in brain penetration evaluation in drug discovery and development.
Liu X; Chen C; Smith BJ
J Pharmacol Exp Ther; 2008 May; 325(2):349-56. PubMed ID: 18203948
[TBL] [Abstract][Full Text] [Related]
17. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
Shawahna R; Decleves X; Scherrmann JM
Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
[TBL] [Abstract][Full Text] [Related]
18. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies.
Xie Y; Ye L; Zhang X; Cui W; Lou J; Nagai T; Hou X
J Control Release; 2005 Jun; 105(1-2):106-19. PubMed ID: 15893839
[TBL] [Abstract][Full Text] [Related]
19. 2B-Trans technology: targeted drug delivery across the blood-brain barrier.
Gaillard PJ; de Boer AG
Methods Mol Biol; 2008; 437():161-75. PubMed ID: 18369968
[TBL] [Abstract][Full Text] [Related]
20. Case study: adapting in vitro blood-brain barrier models for use in early-stage drug discovery.
Vandenhaute E; Sevin E; Hallier-Vanuxeem D; Dehouck MP; Cecchelli R
Drug Discov Today; 2012 Apr; 17(7-8):285-90. PubMed ID: 22033197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
